CBR3 and cardiomyopathy: Hence, in this case the CBR3 V244M polymorphism does not at all explain the reported increased risk of anthracycline-induced cardiomyopathy in African American patients relative to other populations [28], as the allele associated with cardiomyopathy is less common in African Americans.